Progress in the pharmaceutical industry results in the creation of a great number of drugs including substances of various structures and compositions, differing in their pharmacological action and therapeutic properties [I].This situation poses a problem of controlling not only the quality of drugs but the content of drugs (and their metabolites) in various media as well, including biological liquids of the human and animal organism, food products, waste waters of pharmaceutical plants, etc. [2].Potentiometry with ion-selective electrodes (ISE) is still one of the most promising analytical tools capable of determining both inorganic and organic substances in medico-biological practice [3]. Applications of the potentiometry techniques in pharmaceutical analysis and clinical chemistry were reviewed in [4 -8]. There is a constant increase in the number of electrodes capable of selectively identifying various drugs.Below we will summarize the data published between 1988 -I996 on the use of ISE for the purposes of drug analysis.The potentiometric determination of drugs can be based on either direct potentiometry or potentiometric titration. The detection is performed with the aid of transducers, sensitive to either inorganic or organic ions, including biosensors. A large number of biosensors now have been described [9], which are applicable to pharmaceutical and clinical analyses. However, we will concentrate mostly on the potentiometric methods of drug analysis using ISE for inorganic and organic ions.